A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
for Hepatic Insufficiency
Drug: INCB123667
Sites in Orlando +3 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18 - 80
Code: NCT07559474·Phase 1·Recruiting·Listed Apr 2026